| Date | Company | Compound | Disease | Type of agreement | Therapeutic area | Type of Information |
|---|---|---|---|---|---|---|
| 2015-10-01 | Synthetic Biologics (USA - MD) | nomination |
Nomination | |||
| 2015-10-01 | ProBioGen (Germany) Tizona Therapeutics (USA - CA) | GlymaxX® Antibody Glyco-Engineering technology | licensing developement services contract |
Technology - Services - Cancer - Oncology | Licensing agreement | |
| 2015-10-01 | Biogen (USA - MA) Genomics (UK) | Technology - Services | Collaboration agreement | |||
| 2015-09-30 | Sarepta Therapeutics (USA - MA) | nomination |
Rare diseases - Genetic diseases - Neuromuscular diseases | Nomination | ||
| 2015-09-30 | Galena Biopharma (USA - OR) | NeuVax™ (nelipepimut-S) | Ductal Carcinoma in Situ (DCIS) | clinical research |
Cancer - Oncology | Clinical research agreement |
| 2015-09-30 | Voluntis (France) Roche (Switzerland) | therapeutic companion solution for women afflicted with breast cancer | breast cancer | development |
Cancer - Oncology | Development agreement |
| 2015-09-30 | Amatsigroup (France) Pierre Fabre Laboratories (France) | pharmaceutical development center St. Augustin in Corrèze | plant acquisition | Technology - Services | Plant acquisition | |
| 2015-09-29 | The Lead Discovery Center (LDC) (Germany) Infinity Pharmaceuticals (USA - MA) | development licensing |
Cancer - Oncology | Licensing agreement | ||
| 2015-09-29 | Enterome Bioscience (France) | nomination |
Autoimmune diseases - Inflammatory diseases - Digestive diseases | Nomination | ||
| 2015-09-29 | Audentes Therapeutics (USA - CA) | nomination |
Rare diseases - Genetic diseases | Nomination | ||
| 2015-09-29 | Novasep (France) | nomination |
Technology - Services | Nomination | ||
| 2015-09-28 | Ziopharm Oncology (USA - MA) | nomination |
Cancer - Oncology | Nomination | ||
| 2015-09-28 | Ziopharm Oncology (USA - MA) Intrexon (USA - MD) | chimeric regulatory T-cell products (CAR-Treg) | graft-versus-host disease (GvHD) | collaboration R&D |
Transplantation | Collaboration agreement |
| 2015-09-28 | Nuevolution (Denmark) | nomination |
Nomination | |||
| 2015-09-28 | ADC Therapeutics (Switzerland) | nomination |
Cancer - Oncology | Nomination | ||
| 2015-09-28 | Zafgen (USA - MA) | nomination |
Nomination | |||
| 2015-09-28 | Catalyst Biosciences (USA - CA) | nomination |
Nomination | |||
| 2015-09-28 | icometrix (Belgium) Novartis (Switzerland) | MRI biomarkers MSmetrix | multiple sclerosis | collaboration |
Neurodegenerative diseases - Diagnostic | Collaboration agreement |
| 2015-09-27 | Rigel Pharmaceuticals (USA - CA) Aclaris Therapeutics (USA - PA) | JAK inhibitors | alopecia areata | licensing development commercialisation |
Autoimmune diseases - Dermatological diseases | Licensing agreement |
| 2015-09-25 | Galapagos (Belgium) AbbVie (USA - Il) | GLPG0634 | rheumatoid arthritis and other autoimmune diseases, Crohn's disease | termination of the agreement |
Autoimmune diseases – Digestive diseases - Inflammatory diseases - Rheumatic diseases | Termination of an agreement |
